此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Cone Beam CT for Breast Imaging

2013年6月18日 更新者:Koning Corporation

Cone Beam CT for Breast Imaging: A Pilot Study

The objective of this pilot study is to investigate Cone Beam Computed Tomography Imaging (CBCT), with the primary goal, the accumulation of a body of evidence to provide preliminary data for a future extensive clinical trials.

研究概览

地位

完全的

研究类型

观察性的

注册 (实际的)

76

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • New York
      • Rochester、New York、美国、14620
        • University of Rochester Highland Breast Imaging Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

40年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

女性

取样方法

非概率样本

研究人群

In Group I, up to 100 women, at least 40 years of age, who have had a routine standard mammogram read as BI-RADS® 0, 1, 2, or 3 will also undergo 3D breast imaging using a cone beam CT scanner specifically designed to image the breast.

Group II includes forty (40) women, who have had abnormalities detected by physical exam or an imaging modality and are also scheduled for breast biopsy of the index lesion, will also undergo a CBCT of the breast(s), prior to biopsy.

描述

Normal Group:

Inclusion Criteria:

  • Are at least 40 years of age of any ethnicity
  • Had a routine mammogram, read as BI-RADS® 0, 1, 2 or 3
  • Will undergo study imaging no later than six months from date of routine mammogram.
  • Is able to undergo informed consent.

Exclusion Criteria:

  • Pregnancy
  • Lactation
  • Patients with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.
  • Patients who are unable to tolerate study constraints.
  • Patients who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to)

    • Treatment for enlarged thymus gland as an infant
    • Irradiation for benign breast conditions, including breast inflammation after giving birth
    • Treatment for Hodgkin's disease
  • Patients who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.
  • Patients who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to)

    • Tuberculosis
    • Severe scoliosis

Diagnostic Group:

Inclusion Criteria:

  • Women who are at least 40 years of age of any ethnicity
  • Have a palpable abnormality detected by Breast Self Exam (BSE), or Clinical Breast Exam (CBE) or have a non-palpable abnormality detected by an imaging modality
  • After diagnostic work-up are categorized as BI-RADS® 4 or 5.
  • Are scheduled for biopsy either by large gauge needle biopsy or excisional biopsy.
  • Will undergo study imaging prior to biopsy and within four weeks of diagnostic work-up.

Exclusion Criteria:

  • Pregnancy
  • Lactation
  • Patients who have already undergone biopsy for the index lesion
  • Patients who are unable or unwilling to undergo biopsy for the lesion of concern
  • Patients with physical limitations that may prohibit the patient from resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.
  • Patients who are unable to tolerate study constraints.
  • Patients who have received radiation treatments to the thorax or breast area for malignant and nonmalignant conditions, such as (but not limited to)

    • Treatment for enlarged thymus gland as an infant
    • Irradiation for benign breast conditions, including breast inflammation after giving birth
    • Treatment for Hodgkin's disease
  • Patients who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.
  • Patients who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to)

    • Tuberculosis
    • Severe scoliosis

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Normal Group
In Group I, up to 100 women, at least 40 years of age, who have had a routine standard mammogram read as BI-RADS® 0, 1, 2, or 3 will also undergo 3D breast imaging using a cone beam CT scanner specifically designed to image the breast. Of these 100, we hope to enroll at least 30 subjects with mammograms read as BI-RADS® 0 and at least 30 read as BI-RADS® 3. The BI-RADS® 0 category refers to patients for whom additional imaging is required after a screening mammogram provided incomplete diagnostic information.
Diagnostic Group
The goals of Group II will be to compare the CBCT study with standard imaging for the diagnosis of breast disease in palpable or non-palpable breast lesions (having a BI-RADS® score of 4 or 5). Forty (40) women, who have had abnormalities detected by physical exam or an imaging modality and are also scheduled for breast biopsy of the index lesion, will also undergo a CBCT of the breast(s), prior to biopsy.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Image Quality of Cone Beam Breast CT
大体时间:6 years
This study was to evaluate the radiation dose, breast coverage, and image quality of cone-beam breast CT compared with a conventional mammographic examination.
6 years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2006年7月1日

初级完成 (实际的)

2012年6月1日

研究完成 (实际的)

2012年6月1日

研究注册日期

首次提交

2013年6月15日

首先提交符合 QC 标准的

2013年6月18日

首次发布 (估计)

2013年6月19日

研究记录更新

最后更新发布 (估计)

2013年6月19日

上次提交的符合 QC 标准的更新

2013年6月18日

最后验证

2013年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • URMC-001

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅